We found a 38% relative increase in the risk of the development of suspected or confirmed COVID-19 among those prescribed ARBs compared to those prescribed CCBs that did not reach statistical significance in the propensity score matched analysis.
← all excerpts
Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
1
—
—